Northern Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18B | Buy |
2,658,581
+39,189
| +1% | +$17.4M | 0.16% | 115 |
|
|
2025
Q1 | $1.27B | Sell |
2,619,392
-101,657
| -4% | -$49.3M | 0.19% | 104 |
|
|
2024
Q4 | $1.1B | Buy |
2,721,049
+355,057
| +15% | +$143M | 0.16% | 115 |
|
|
2024
Q3 | $1.1B | Sell |
2,365,992
-167,912
| -7% | -$78.1M | 0.18% | 105 |
|
|
2024
Q2 | $1.19B | Sell |
2,533,904
-44,533
| -2% | -$20.9M | 0.2% | 90 |
|
|
2024
Q1 | $1.08B | Sell |
2,578,437
-102,160
| -4% | -$42.7M | 0.19% | 102 |
|
|
2023
Q4 | $1.09B | Sell |
2,680,597
-132,966
| -5% | -$54.1M | 0.2% | 100 |
|
|
2023
Q3 | $978M | Buy |
2,813,563
+131,539
| +5% | +$45.7M | 0.19% | 102 |
|
|
2023
Q2 | $944M | Sell |
2,682,024
-94,671
| -3% | -$33.3M | 0.18% | 107 |
|
|
2023
Q1 | $875M | Sell |
2,776,695
-74,864
| -3% | -$23.6M | 0.17% | 114 |
|
|
2022
Q4 | $823M | Sell |
2,851,559
-36,439
| -1% | -$10.5M | 0.17% | 117 |
|
|
2022
Q3 | $836M | Sell |
2,887,998
-48,936
| -2% | -$14.2M | 0.19% | 102 |
|
|
2022
Q2 | $828M | Buy |
2,936,934
+46,981
| +2% | +$13.2M | 0.18% | 109 |
|
|
2022
Q1 | $754M | Sell |
2,889,953
-18,399
| -0.6% | -$4.8M | 0.13% | 142 |
|
|
2021
Q4 | $639M | Sell |
2,908,352
-86,138
| -3% | -$18.9M | 0.1% | 175 |
|
|
2021
Q3 | $543M | Buy |
2,994,490
+21,674
| +0.7% | +$3.93M | 0.1% | 186 |
|
|
2021
Q2 | $599M | Sell |
2,972,816
-5,434
| -0.2% | -$1.1M | 0.11% | 169 |
|
|
2021
Q1 | $640M | Sell |
2,978,250
-44,254
| -1% | -$9.51M | 0.12% | 155 |
|
|
2020
Q4 | $714M | Sell |
3,022,504
-75,401
| -2% | -$17.8M | 0.14% | 137 |
|
|
2020
Q3 | $843M | Buy |
3,097,905
+119,997
| +4% | +$32.7M | 0.18% | 100 |
|
|
2020
Q2 | $865M | Buy |
2,977,908
+117,949
| +4% | +$34.2M | 0.2% | 90 |
|
|
2020
Q1 | $681M | Buy |
2,859,959
+18,222
| +0.6% | +$4.34M | 0.2% | 105 |
|
|
2019
Q4 | $622M | Sell |
2,841,737
-110,483
| -4% | -$24.2M | 0.14% | 143 |
|
|
2019
Q3 | $500M | Buy |
2,952,220
+8,440
| +0.3% | +$1.43M | 0.12% | 171 |
|
|
2019
Q2 | $540M | Buy |
2,943,780
+33,009
| +1% | +$6.05M | 0.13% | 155 |
|
|
2019
Q1 | $535M | Buy |
2,910,771
+31,978
| +1% | +$5.88M | 0.13% | 145 |
|
|
2018
Q4 | $477M | Buy |
2,878,793
+98,585
| +4% | +$16.3M | 0.13% | 146 |
|
|
2018
Q3 | $536M | Sell |
2,780,208
-22,732
| -0.8% | -$4.38M | 0.13% | 150 |
|
|
2018
Q2 | $476M | Sell |
2,802,940
-6,684
| -0.2% | -$1.14M | 0.12% | 166 |
|
|
2018
Q1 | $458M | Sell |
2,809,624
-33,696
| -1% | -$5.49M | 0.12% | 174 |
|
|
2017
Q4 | $426M | Sell |
2,843,320
-50,060
| -2% | -$7.5M | 0.11% | 186 |
|
|
2017
Q3 | $440M | Buy |
2,893,380
+182,130
| +7% | +$27.7M | 0.11% | 174 |
|
|
2017
Q2 | $349M | Buy |
2,711,250
+6,055
| +0.2% | +$780K | 0.1% | 207 |
|
|
2017
Q1 | $296M | Buy |
2,705,195
+59,428
| +2% | +$6.5M | 0.09% | 238 |
|
|
2016
Q4 | $195M | Sell |
2,645,767
-327,029
| -11% | -$24.1M | 0.06% | 314 |
|
|
2016
Q3 | $259M | Buy |
2,972,796
+29,351
| +1% | +$2.56M | 0.08% | 248 |
|
|
2016
Q2 | $253M | Buy |
2,943,445
+30,442
| +1% | +$2.62M | 0.08% | 250 |
|
|
2016
Q1 | $240M | Buy |
2,913,003
+8,430
| +0.3% | +$695K | 0.08% | 250 |
|
|
2015
Q4 | $365M | Sell |
2,904,573
-233,754
| -7% | -$29.4M | 0.12% | 163 |
|
|
2015
Q3 | $327M | Sell |
3,138,327
-84,732
| -3% | -$8.82M | 0.11% | 184 |
|
|
2015
Q2 | $398M | Buy |
3,223,059
+74,500
| +2% | +$9.2M | 0.12% | 167 |
|
|
2015
Q1 | $371M | Sell |
3,148,559
-49,433
| -2% | -$5.83M | 0.11% | 186 |
|
|
2014
Q4 | $380M | Buy |
3,197,992
+21,376
| +0.7% | +$2.54M | 0.11% | 182 |
|
|
2014
Q3 | $357M | Buy |
3,176,616
+239,143
| +8% | +$26.9M | 0.11% | 173 |
|
|
2014
Q2 | $278M | Sell |
2,937,473
-275,784
| -9% | -$26.1M | 0.09% | 218 |
|
|
2014
Q1 | $227M | Buy |
3,213,257
+227,875
| +8% | +$16.1M | 0.07% | 271 |
|
|
2013
Q4 | $222M | Sell |
2,985,382
-22,077
| -0.7% | -$1.64M | 0.07% | 262 |
|
|
2013
Q3 | $228M | Buy |
3,007,459
+675,024
| +29% | +$51.2M | 0.08% | 239 |
|
|
2013
Q2 | $187M | Buy |
+2,332,435
| New | +$187M | 0.07% | 283 |
|